http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104293791-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104293791-B |
| titleOfInvention | New applications of the miR 200b in the protein expression inhibitor of Rac 1 is prepared |
| abstract | The invention belongs to biology field, and in particular to new applications of the miR 200b in the protein expression inhibitor of Rac 1 is prepared.Invention initially sets up HIBI model, carries out miRNA activators or the antagonist transfection of respective sets, is overexpressed and low expression miR 200b respectively.As a result after showing transfection miR 200b, the protein expressions of Rac 1 reduce, and after antagonism miR 200b, the protein expressions of Rac 1 further raise, and illustrate that expression of the miR 200b by adjusting the albumen of Rac 1 participates in the repair of hypoxic-ischemic brain damage.The invention provides miR 200b new opplication, can effectively adjust the expression of the albumen of Rac 1, has important clinical value. |
| priorityDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.